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1Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK; and 2Department of Bioengineering, Imperial College, London, UKIncreased urinary albumin excretion is a key feature of
glomerular disease but has limitations as a measure of
glomerular permeability. Here we describe a novel assay to
measure the apparent albumin permeability of single
capillaries in glomeruli, isolated from perfused kidneys
cleared of red blood cells. The rate of decline of the
albumin concentration within the capillary lumen was
quantiﬁed using confocal microscopy and used to calculate
apparent permeability. The assay was extensively validated
and provided robust, reproducible estimates of glomerular
albumin permeability. These values were comparable with
previous in vivo data, showing this assay could be applied
to human as well as rodent glomeruli. To conﬁrm this, we
showed that targeted endothelial glycocalyx disruption
resulted in increased glomerular albumin permeability in
mice. Furthermore, incubation with plasma from patients
with post-transplant recurrence of nephrotic syndrome
increased albumin permeability in rat glomeruli compared
to remission plasma. Finally, in glomeruli isolated from rats
with early diabetes there was a signiﬁcant increase in
albumin permeability and loss of endothelial glycocalyx,
both of which were ameliorated by angiopoietin-1. Thus, a
glomerular permeability assay, producing physiologically
relevant values with sufﬁcient sensitivity to measure
changes in glomerular permeability and independent of
tubular function, was developed and validated. This assay
signiﬁcantly advances the ability to study biology and
disease in rodent and human glomeruli.
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T he ability to measure glomerular permeability isessential in the detection and assessment of glomerulardisease. Albuminuria is the standard measure; however,
it does not accurately reﬂect glomerular permeability. This is
due to confounding changes in local hemodynamics, as well
as tubular reabsorption of ﬁltered albumin.1 For experimental
studies of human glomerular permeability, measurements of
albuminuria are not possible. Therefore, the development of a
reliable, physiologically relevant assay to directly measure
glomerular permeability using isolated glomeruli would be
very useful and independent of confounding variables. We
have previously developed a reliable assay of water perme-
ability in isolated glomeruli2 and here we describe the
development of an albumin permeability assay. In 1992, Savin
et al. modiﬁed an isolated glomerular oncometric assay,
originally developed to assess hydraulic conductivity,3 to
measure glomerular reﬂection coefﬁcients4 and further
modiﬁed the assay in 2015 for higher thoughput.5 However,
this assay is limited to measuring relative changes in perme-
ability. Daniels et al. developed an ex vivo method to quantify
the apparent diffusion of ﬂuorophores across individual
glomerular capillaries in cross-section,6 yet permeability
values were signiﬁcantly higher than values previously
measured in vivo.7 Using similar principles we developed an
assay to measure apparent, diffusive glomerular albumin
permeability in isolated glomeruli deriving physiologically
relevant values.
We aimed to develop and characterize an assay that could
sensitively measure glomerular albumin permeability and
demonstrate its utility under different pathophysiological
conditions, in different species. The pathophysiological vari-
ables tested were: (i) disruption of endothelial glycocalyx,8–10
(ii) exposure to plasma from patients with recurrence of
nephotic syndrome posttransplant,11,12 (iii) early dia-
betes,13,14 and (iv) rescue of glomerular permeability in dia-
betes using angiopoietin-1.15,161
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Set-up and characterization of a novel glomerular albumin
permeability assay
The abdominal aorta of rats andmice were cannulated to perfuse
both kidneys (Figure 1a). Kidneys were perfused ﬁrst with
mammalian 4%Ringer bovine serumalbumin (BSA) toﬂush out
red blood cells (which interfere with analysis). They were then
perfused with octadecyl rhodamine B chloride (R18, a lipophilic
membrane stain) in 4% Ringer BSA, to label cell membranes red
in order to distinguish the glomerular capillary walls. This was
followed by perfusion with Alexa Fluor 488 (AF488; Thermo
Fisher Scientiﬁc, Waltham, MA) labeled 4% BSA. Perfused
glomeruli were isolated by sieving, then incubated in AF488-BSA
with or without treatments. A single glomerulus was then placed
in an adapted petri dish (Figure 1b) on a confocal microscope in
AF488-BSA. This was trapped to micro-occlude the afferent and
efferent arterioles using a glass micropipette, thereby sealing the
glomerulus so that any movement of molecules could only occurFigure 1 | Glomerular albumin permeability assay setup and characte
aorta, which was cannulated with a blunted needle, as detailed in (i) and
shows an inverted confocal microscope equipped with a modiﬁed Petri
thickness) attached on the top and connected to a perfusion and a suct
glass restrainer positioned using a (3) micromanipulator. Ringer bovine
perfusion system and simultaneously removed though a (5) suction syste
(20–60 seconds). Arrows indicate the direction of ﬂow. A schematic is s
micromanipulator connected to a restraining glass pipette. (bii) Numbe
loops of a trapped glomerulus is shown. The capillary wall is labeled red w
colocalization). The arrow indicates a spherical capillary, chosen for analys
and bath, respectively (bar ¼ 5 mM). (cii) The decline in ﬂuorescence in
represent the ﬂux of movement of ﬂuorescently labeled albumin molecul
ﬂuorescence intensity of the bath after the wash (ROI2). The decline in ﬂ
r2 ¼ 0.97). (d) Mean ﬂuorescence intensity was plotted against AF488-B
compared with the FI values at the end of the experiment (after 90 min
intensity is plotted against time and is not different than background. (
glomeruli were analyzed for different periods of time following the washo
was 1 minute (arrow) because this had a signiﬁcant number of frames t
treatment groups. To optimize viewing of this image, please see the on
2across the capillary walls by diffusion. Regions of interest (ROI)
were chosen within circular capillary loops (ROI1) and external
to the glomerulus (ROI2, Figure 1ci). The 4% AF488-BSA was
exchanged for iso-oncotic unlabeled 4% BSA, and the initial
change in ﬂuorescence intensity was measured over time in both
ROI (Figure 1cii). The ﬂuorescence intensity and concentration
of AF488-BSAwere linearly related (Figure 1d), the ﬂuorescence
intensity of AF488 was not impacted by time (Figure 1e), and
AF488 free dye at 0.07% or below had no impact on ﬂuorescence
intensity (Figure 1f). The decline in ﬂuorescence intensity in
ROI1 was measured over 1 minute, which was the minimum
length of time necessary to give sufﬁcient data points to represent
the initial decline (Figure 1g).
To demonstrate that macromolecules were effectively
restricted by glomeruli in this assay, 2 different molecular
weight dextrans conjugated with ﬂuorescein isothiocyanate
(FITC) were used. There was a linear relationship between
low molecular weight (LMW) and high molecular weightrization. (a) A midline laparotomy was used to expose the abdominal
(ii). AA, abdominal aorta; IVC, inferior vena cava. (bi) The photograph
dish consisting of a central hole with a glass coverslip (0.085-mm
ion system. Glomeruli were trapped on the (1) glass coverslip by a (2)
serum albumin (BSA) was pumped into the Petri dish though a (4)
m to wash the glomeruli of surrounding Alexa Fluor 488 (AF488) BSA
hown to reﬂect the setup showing a glomerulus trapped by a
rs relate to those shown in (bi). (ci) An image of peripheral capillary
ith R18, and AF488-BSA ﬁlls the lumen (labeled yellow where there is
is. Region of interest (ROI) 1 and ROI2 are shown in the capillary lumen
tensity of labeled albumin over time is plotted. The green boxes
es from the lumen to the bath (ROI1), and the blue line represents the
uorescence intensity follows a single exponential decay (green boxes,
SA concentrations. (e) The initial ﬂuorescence intensity values were
utes of laser exposure; paired t test, P ¼ 0.20). Free dye ﬂuorescence
f) Permeability between decellularized and normal (vehicle-treated)
ut period. (g) The period chosen for analysis after the washout period
o analyze (30 seconds was too few) and differentiated well between
line version of this article at www.kidney-international.org.
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(Supplementary Figure S1A). Isolated glomeruli were signif-
icantly more permeable to LMW FITC-dextran (4 kDa)
compared with HMW FITC-dextran (500 kDa), as predicted
(Supplementary Figure S1B). However, baseline values for
FITC-500 kDa dextran were much higher than anticipated.
This is likely due to the overestimation of permeability of
dextran due to the rapid photobleaching of FITC in our
system (Supplementary Figure S1Ci and Cii). Although these
data suggest that FITC is inferior to AF488 in our assay, the
data nevertheless conﬁrm lower glomerular permeability to a
higher–molecular weight tracer.
The glomerular permeability assay accurately and
reproducibly measures albumin permeability
The apparent glomerular albumin permeability (Ps’alb) assay
was used to demonstrate that physiologically relevant
permeability values could be measured in glomeruli from
different species, including humans. The cellular components
of the glomerular ﬁltration barrier contribute substantially to
macromolecular permeability control.6 Therefore intact ro-
dent and human glomeruli were compared with partially
decellularized glomeruli to demonstrate that the assay couldFigure 2 | The glomerular albumin permeability assay demonstrates
and (d) mice (FVB, mixed background) were perfused with Alexa Fluor 4
Human unused donor kidneys were perfused, and glomeruli were isolat
images of (a) vehicle-treated and (b) decellularized glomeruli are shown. (
pipette, (ii) shows a higher magniﬁcation of (i) as indicated, and (iii) sh
glomeruli with Höescht 33342 staining. These demonstrate (i, ii) the los
glomeruli. Bar ¼ 50 mm (i, iii) or 5 mM (ii). (c,e) Apparent glomerular alb
values from our glomerular permeability assay (bold black arrows, # ¼ hu
those previously reported and shown on a logarithmic scale (citation num
coefﬁcients were calculated from Ps’alb (shown in Table 2) and compare
rat, þ ¼ mouse), shown on a logarithmic scale (for details see Supplem
Table 3). (h) To compare human Ps’alb values more directly with experim
then incubated in ﬂuorophores, and Ps’alb was measured (unpaired t test
number of glomeruli in parentheses and the number of animals or huma
number of animals per group. Bonfferoni post hoc tests were used exce
distributed and therefore with which Mann-Whitney post hoc tests were
see the online version of this article at www.kidney-international.org.
Kidney International (2018) -, -–-measure changes in glomerular permeability associated with
loss of the cellular components in a similar manner to that
used by Daniel’s et al.6 Confocal ﬂuorescence imaging
conﬁrmed removal of cell membranes from glomeruli (by loss
of R18 staining) although there was some residual nuclear
material (Figure 2a and b). Ps’alb values were signiﬁcantly
higher for partially decellularized glomeruli than intact
glomeruli in all species examined (Figure 2c–e). Human, rat,
and mouse Ps’alb values were all of a similar magnitude to
those previously reported in systemic vessels in vivo (and
ex vivo) (Figure 2f, Table 1). Glomerular permeability is more
often measured by glomerular sieving coefﬁcients (GSC)
in vivo. To understand how Ps’alb values related to previously
published GSC values in rat, mouse and human glomeruli,
the membrane pore model of permeability was used to
convert Ps’alb to equivalent values of GSC (Table 2) (see
“Calculation of GSC values” in Supplementary Methods for
details). Human-, rat-, and mouse-converted GSC values
(0.00182, 0.0027, and 0.002, respectively) were very similar to
those previously reported (Figure 2g, Table 3). Importantly,
we have shown for the ﬁrst time that human Ps’alb can be
measured directly and with physiologically relevant values.
Methodology varied between rodent and human glomeruliphysiologically relevant values in rodents and humans. (a–c,f) Rats
88 bovine serum albumin (AF488-BSA) (green) and R18 (red). (e,h)
ed and then incubated sequentially in ﬂuorophores. Representative
i) shows a ﬂuorescent image of a whole glomerulus trapped by a glass
ows representative phase contrast/ﬂuorescent images of the whole
s of R18 and (iii) the partial loss of Höechst 33342 (blue) in treated
umin permeability (Ps’alb) was measured (unpaired t tests). (f) Ps’alb
man Ps’alb, * ¼ rat Ps’alb, and þ ¼mouse Ps’alb) were compared with
bers refer to references described in Table 1). (g) Glomerular sieving
d with previously reported values (bold black arrows, # ¼ human,* ¼
entary Methods; citation numbers refer to references described in
ental values, aged mouse (C57/BL6, 1-year-old) kidneys were perfused
). Data for Ps’alb assays are presented as glomerular averages, with the
ns before the parentheses. Statistical analyses were performed on the
pt with comparisons of human data, which were not normally
used. *P < 0.05, **P < 0.01. To optimize viewing of this image, please
3
Table 1 | Ps’alb values in previously described models
Species Method Ps’alb value Study
1 Frog In vivo mesenteric
vessel
cannulation
4e-006 cm/s (15 cm
H2O capillary
pressure)
Huxely et al., 19877
2 Rat Ex vivo isolated
glomeruli
1.36e-0.006 cm/s Daniels et al., 19936
3
4
5
Pig Ex vivo, coronary
microvessel,
isolated and
cannulated
2.85e-006 cm/s
3.92e-006 cm/s (11
cm H2O capillary
pressure)
4.0e-007cm/s (15.3
cm H2O arteriole
pressure)
Yuan et al., 200046
Yuan et al., 199347
Huxley et al., 200048
6 Rat In vivo venular
microvessels
0.92e-006 cm/s (20
cm H2O
microvessel
pressure)
Adamson et al.,
201449
7 Rat In vivo mesenteric
vessel
cannulation
0.82e-006 cm/s Cai et al., 198550
Ps’alb, apparent glomerular albumin permeability.
Table 3 | GSC values in previously described models
Species Method Ps’alb Study
1
2
Rat In vivo, confocal,
glomerular
0.0027
0.0004
Stolte et al., 197951
Tanner et al., 200952
3 Mouse In vivo, multiphoton
imaging, glomerular
0.0025 Nakano et al., 201253
4 Mouse Cooled isolated perfused
kidney
0.0023 Jeansson et al., 20038
5 Human Fanconi syndrome,
HPLC, and MALDI-TOF
MS urine analysis
0.00008 Norden et al., 200434
6 Rat Fractional micropuncture 0.0006 Tojo and Endou, 199254
7 Rat Labeled normal and
neutral albumin
0.0006 Bertolatus and
Hunsicker, 198555
8 Rat Intravital 2-photon
microscopy
0.034 Russo et al., 200756
HPLC, high-performance liquid chromatography; MALDI-TOF MS, Matrix-assisted
laser desorption ionization-time of ﬂight mass spectrometry; Ps’alb, apparent
glomerular albumin permeability.
bas i c re sea r ch S Desideri et al.: Glomerular albumin permeabilitypreparations, because it was impractical to perfuse whole
human kidneys with ﬂuorophores, although all kidneys were
perfused with a physiological salt solution. There was also a
24-hour time delay in processing human kidneys. In 1 set of
experiments, rat and mouse glomeruli were therefore also
incubated ex vivo with ﬂuorophores in the same way as hu-
man glomeruli. Glomeruli treated in this way still had
signiﬁcantly lower permeability than the human glomeruli,
conﬁrming that the different methods for applying ﬂuo-
rophores did not account for species differences. Further-
more, there were no signiﬁcant differences in Ps’alb between
these 2 methodologies in either rats or mice (Supplementary
Figure S2A and B). Glomeruli that were isolated for up to 4
hours before measurements did not have signiﬁcantly
different Ps’alb, suggesting that up until this point glomerular
permeability is stable (Supplementary Figure S2C). All our
previous observations on rodent glomeruli were performed
within this time frame. In another set of experiments, mouse
kidneys were kept on ice for 24 hours before glomeruli were
isolated to compare with the delayed processing time frame of
human kidneys. There was a signiﬁcant increase in Ps’alb in
mouse glomeruli processed after 24 hours (SupplementaryTable 2 | GSC converted from Ps’alb for human rat and mouse
glomeruli
Coefﬁcient Mouse Rat Human
P albumin (cm/s) 4.3 x 10–7 4.5 x 10–7 8.942 x 10–7
Lp cm/(sec dyne) x 10–8 2.1 1.629 2.735
Single pore population,
pore radius, R (nm)
3.742 3.69 3.776
Single pore: q (GSC) 0.0026 0.00068 0.0016
Two-pore population: RL ¼ 11 nm,27
Equivalent q, (GSC)
0.002 0.0027 0.00182
GSC, glomerular sieving coefﬁcient; Ps’alb, apparent glomerular albumin
permeability.
See explanation in Supplementary Materials and Methods.
4Figure 2D), indicating that the prolonged cold storage of
human organs inherent in the retrieval process may provide
some of the explanation for higher permeability values. Ps’alb
was signiﬁcantly higher for human glomeruli than these
mouse glomeruli, indicating a species difference or other re-
sidual differences (Figure 2h). Of note, mice in these exper-
iments were aged to 1 year to relate to aged human kidneys
(from donors 72  3.1 years of age).
Utility of the glomerular albumin permeability assay
We took a number of approaches to test that the glomerular
Ps’alb assay could effectively measure changes in glomerular
macromolecular permeability.
Endothelial glycocalyx (eGLX) dysfunction. eGLX is situated
on the luminal side of glomerular and other endothelial
cells17,18 and is the ﬁrst (most “upstream”) component of the
glomerular ﬁltration barrier to encounter albumin.19 Damage
to eGLX decreases glomerular ﬁltration barrier albumin
permselectivity as demonstrated by fractional clearance of
labeled Ficoll and albumin in cooled isolated perfused mouse
kidneys.8,9 To test the physiological sensitivity of the assay,
eGLX dysfunction was induced with an i.v. bolus of hyal-
uronidase and chondroitinase 30 minutes before killing.
Representative electron micrographs are shown to demon-
strate systemic eGLX removal by GAG-degrading enzymes in
coronary and glomerular microvessels (Figure 3a). While
eGLX depth was not signiﬁcantly decreased, vessel coverage
by eGLX was (Figure 3b), suggesting a “patchy” coverage as
demonstrated in the micrographs. Of note, we have previ-
ously shown that both vessel coverage by eGLX and eGLX
depth are inversely related to permeability.20 The enzymes
induced a signiﬁcant increase in Ps’alb as anticipated
(Figure 3c). No signiﬁcant differences were found in podocyte
foot process width, foot process length, number of foot
processes per mm GBM, slit diaphragm length, number of
endothelial fenestration per mm GBM, and GBM width (data
not shown), suggesting that effects of these enzymes on the
glomerular ﬁltration barrier are limited to the eGLX.Kidney International (2018) -, -–-
Figure 3 | The glomerular albumin permeability assay can be used to examine the contribution of endothelial glycocalyx (eGLX)
dysfunction and human steroid-resistant nephrotic syndrome (SRNS) recurrence plasma to glomerular permeability. Glomeruli were
isolated from mice treated with glycosaminoglycan enzymes or vehicle to induce systemic eGLX disruption. (a) Mice were perfusion-ﬁxed
in the presence of Alcian blue, and representative electron micrographs of eGLX (black arrows) are shown for coronary and glomerular
microvessels (bar ¼ 500 nm). (b) Quantiﬁcation of (i) eGLX depth and (ii) vessel coverage by eGLX is shown (unpaired t test). (c) Under the
same conditions, mice were perfused with R18 then Alexa Fluor 488 bovine serum albumin (AF488-BSA), glomeruli were isolated, and apparent
glomerular albumin permeability (Ps’alb) was measured (unpaired t test). Rat kidneys were perfused with R18 and AF488-BSA, then glomeruli
were isolated and incubated in 10% human SRNS recurrence or remission plasma or control (Ringer BSA) for 1 hour at 37 C. (d) Ps’alb was
measured (1-way analysis of variance with Bonferroni post hoc tests indicated). Number of rats used, n ¼ 5; number of patient plasma pairs,
n ¼ 4. Total number of glomeruli shown. Data for Ps’alb assay are presented as glomerular averages with the number of glomeruli in
parentheses and the number of animals before the parentheses. Statistical analyses were performed on the number of animals per group.
*P < 0.05, **P < 0.01, *** P < 0.001. EC, endothelial cells; GBM, glomerular basement membrane; GEnC, glomerular endothelial cells; Pod,
podocyte foot processes. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org.
S Desideri et al.: Glomerular albumin permeability ba s i c re sea r chHuman steroid-resistant nephrotic syndrome (SRNS) plasma. To
test the use of clinical samples on this assay, plasma was used
from individuals with SRNS that had undergone plasma ex-
change during periods of posttransplant recurrence, or subse-
quent remission, with the assumption being that in recurrence
the “permeability factors” were present and in remission they
were not.21 Rats were perfused with R18 and AF488-BSA, and
glomeruli were isolated and incubated in 10% plasma from
SRNS patients for 1 hour. SRNS recurrence plasma signiﬁcantly
increased Ps’alb in rat glomeruli compared with remission
plasma, which was very similar to control conditions (no
plasma) (Figure 3d).
The Ps’alb assay is sufﬁciently sensitive to measure early
glomerular damage
To further investigate the sensitivity of the Ps’alb assay, a rat
model of early glomerular damage was utilized. Rats given
streptozotocin (STZ, a type 1 model of diabetes) were
signiﬁcantly hyperglycemic at 1 week after injection, which
was sustained (Figure 4a), conﬁrming diabetes. Weight gain inKidney International (2018) -, -–-diabetic rats was signiﬁcantly reduced as anticipated
(Figure 4b). Diabetic rats showed a modest, but signiﬁcant,
increase in urinary albumin-to-creatinine ratio (1.7-fold in-
crease) compared with control rats 4 weeks after injection
(Figure 4c), suggesting a modest increase in glomerular leak
of albumin. It is important to note that albuminuria is in-
dependent of STZ-induced renal toxicity in this rat model
(although total proteinuria is not).22 Mesangial matrix
expansion was assessed using periodic acid–Schiff staining,
demonstrating a mild but signiﬁcant increase in glomerular
ﬁbrosis in diabetic rats (Figure 4di and ii). Electron micro-
scopy was used to analyze glomerular ultrastructure. No
signiﬁcant changes were observed (representative images
Figure 4ei–iv, data not shown). Together these data conﬁrm
that these diabetic rats have early signs of glomerular damage
rather than established diabetic nephropathy. Diabetes
induced a signiﬁcant increase in Ps’alb, which was amelio-
rated by the paracrine growth factor, angiopoietin-1 (Ang1),
to a level comparable with nondiabetic glomeruli (Figure 4f),
supporting previously published results.15 Ang1 alone had no5
Figure 4 | The glomerular albumin permeability assay is sufﬁciently sensitive to measure diabetes-induced changes associated with
mild kidney dysfunction. (a) Blood glucose (n ¼ 4) and (b) body weight (n ¼ 6) were measured weekly before and after the induction of
diabetes in rats (2-way analysis of variance, Bonferroni post hoc indicated on the graph). (c) Urinary albumin-to-creatinine ratios (uACR) were
measured at week 0 and week 4 in control (sham) and diabetic rats (n ¼ 6, unpaired t test). Periodic acid–Schiff staining was (di) imaged (bar ¼
25mm) and (dii) quantiﬁed between control and diabetic rats 4 weeks after streptozotocin (STZ) was administered (unpaired t test, n ¼ 4).
Diabetic (ii, iv) and control rats (i, iii) were perfusion-ﬁxed 4 weeks after STZ, and kidneys were processed and imaged by transmission
electron microscopy. (e) Representative images of the glomerulus (i, ii; bar ¼ 10 mm) and higher magniﬁcations of the glomerular ﬁltration
barrier (GFB; iii, iv; bar ¼ 500 nm) are shown. (f) Glomeruli isolated from control or diabetic rats at 4 weeks were incubated in vehicle or Ang-1
(200 ng/ml) for 1 hour, and apparent glomerular albumin permeability was measured (1-way analysis of variance, Bonferroni post hoc tests
indicated on the graph). Data are presented as glomerular averages with the number of glomeruli in parentheses and the number of animals
before the parentheses. Statistical analyses were performed on the number of animals. Diabetic and control rats were given Ang1 i.p. 30
minutes before killing. They were then whole-body perfusion-ﬁxed in the presence of Alcian blue. (gi) Representative transmission electron
micrographs are shown (bar ¼ 100 nm). (gii) EGLX depth and (giii) coverage were quantiﬁed (1-way analysis of variance with Bonferroni post
hoc tests indicated). *P < 0.05, **P < 0.01, *** P < 0.001. CL, capillary loop; eGLX, endothelial glycocalyx; fen, fenestrations; FP, foot processes;
GBM, glomerular basement membrane; GEnC, glomerular endothelial cells; GFB, glomerular ﬁltration barrier. To optimize viewing of this image,
please see the online version of this article at www.kidney-international.org.
bas i c re sea r ch S Desideri et al.: Glomerular albumin permeabilityeffect compared with sham, suggesting no effect on otherwise
healthy capillaries under nondiabetic conditions. eGLX is
damaged in models of diabetes.23 We have previously shown
that Ang1 acts on glomerular endothelial cells24 and that it
can increase eGLX depth and reduce microvascular perme-
ability in a different capillary bed.16 Therefore, we investi-
gated whether the protective effect of Ang1 was associated
with restoration of eGLX damage. Glomerular eGLX depth
and coverage was signiﬁcantly reduced in diabetic rats
compared with control rats, but was restored by Ang1
(Figure 4gi–iii). Together these data conﬁrm that the Ps’alb
assay can sensitively measure early changes in glomerular
barrier function associated with eGLX dysfunction.
DISCUSSION
We have developed a glomerular albumin permeability assay
that gives physiologically relevant permeability values and
allows human Ps’alb measurements for the ﬁrst time. We6demonstrated utility of the assay and conﬁrmed that it was
sufﬁciently sensitive to measure early decline in glomerular
permeability and could be used in conjunction with clinical
samples.
Ps’alb measurements were reassuringly close to those
measured previously in vivo7,8 and even lower than previously
measured Ps’alb values ex vivo.6 This demonstrates the
strength of using permeability values compared with using
relative changes in permeability, as used previously.4 It allows
us to directly compare with previously reported values and to
interpret our data in the context of health and disease.
Knowing that the permeability of glomeruli are within the
physiological range conﬁrms the relevance of our observa-
tions to the in vivo situation.
Typically, previously published values of glomerular
albumin permeability are presented as GSC. These reﬂect
the fraction of plasma albumin that can pass though the
glomerular ﬁltration barrier, expressed as values over theKidney International (2018) -, -–-
S Desideri et al.: Glomerular albumin permeability ba s i c re sea r chrange of 0 to 1, with 1 being free passage of albumin. Theories
of glomerular capillary permeability to ﬂuid and albumin are
of 3 general categories: (i) pore theories,25–27 (ii) ﬁber-matrix
theories,28–31 and (iii) structural theories, which model
diffusion and ﬂow through geometric simpliﬁcations of
pathways proposed for water and albumin from tissue ul-
trastructure.32 We have used pore theory, not because we
believe the pathways between capillary lumen and Bowman’s
space are cylindrical pores, but because it is an internally
consistent mathematical model that allows one to estimate
the GSC from the diffusional permeability coefﬁcients and
glomerular hydraulic conductivity, using the minimum
number of assumptions. The ﬁber-matrix theories, while
more realistic in terms of representing the molecular sieving
processes through the eGLX and the GBM, are able to
describe diffusion of solutes through a matrix of cylindrical
ﬁbers of a given radius and occupying a known fraction of the
matrix, but calculation of ﬂow and solvent drag of solutes
through the matrix require additional assumptions including
the orientation of the ﬁbrous molecules with respect to the
ﬂow.33 Furthermore, pore theory has been used to interpret
the GSC for albumin and a range of neutrally charged pro-
teins in rats,27 and this allows us to compare our calculated
estimates of GSC from rat glomerular capillary P’alb
coefﬁcients with measured values of GSC in the rat. Like Lund
et al.27 we assumed the pathways between glomerular capil-
lary lumen to consist of 2 populations of pores: a very large
population of “small pores” that accounted for the ﬂow and
diffusion of nearly all the water and small hydrophilic solutes,
and a very small population of large pores through which
most of the albumin would be ﬁltered. The calculations of
GSC from our measurements of Ps’alb and published values
for glomerular capillary hydraulic conductivity are given in
the Supplementary Material (see “Calculation of GSC
values”). In brief, analysis of our measured values of Ps’alb
gave a maximum value for the radius of the small pore
population and, combining this with measured glomerular
capillary hydraulic conductivity values and the value assumed
by Lund et al.27 for the radii of the large pores, allowed us to
estimate the fractions of water ﬂow through small and large
pore populations and the GSC. The calculated values of GSC
for rats, mice, and humans (0.00182, 0.0027, and 0.002,
respectively) were very similar to in vivo rat values and iso-
lated cooled mouse kidney values.8 GSC were estimated
previously in isolated rat glomeruli giving values of 0.13 
0.02,5 2 orders of magnitude greater than our and other
reported values. We have shown the ﬁrst direct measurements
of human Ps’alb, from which we calculated GSC. These were
higher than those measured from patients with Fanconi
syndrome (0.00008, the only other human GSC value).
However, that published value assumed that tubular reab-
sorption is completely abolished (which may not be the
case)34 and is very low even compared with other in vivo
values measured directly. Of course, we have not measured
GSC directly, and we recognize the limitations of using pore
theory to calculate these.Kidney International (2018) -, -–-Our work conﬁrms that targeted disruption of eGLX
signiﬁcantly changes Ps’alb. Previous work has demon-
strated albumin leak (by immunogold) across the GFB due
to eGLX dysfunction over a period of 4 weeks.10 Increased
Ps’alb was measured in glomeruli isolated from diabetic rats,
even in those with mild proteinuria, suggesting that the
assay is sensitive to early changes in renal function Albu-
minuria can be impacted by tubular reuptake of albumin
resulting in variable urinary albumin-to-creatinine ratio
values in experimental diabetic models.35 When tubular
reuptake of albumin was inhibited using an inducible
transgenic megalin knockout mouse line, this resulted in a
10-fold increase in urinary albumin secretion in diabetic
mice.36 Because our Ps’alb assay measures albumin perme-
ability directly, it circumvents this potential confounding
factor and conﬁrms that glomeruli are a target in diabetic
kidney disease.
eGLX dysfunction is associated with increased vascular
permeability,37,38 including albuminuria, indicating dysfunc-
tion of the glomerular ﬁltration barrier.13,14,39 Albuminuria is
also associated with reduced eGLX dimensions40 including in
patients with type 141 and type 2 diabetes.14 Here we
demonstrate that Ang1 reduced elevated Ps’alb in diabetic
rats, consistent with previous reports,15,42 and also restored
the diabetes-associated loss of glomerular endothelial cell
GLX. Of note, because these diabetic rats had low-level pro-
teinuria and minimal ultrastructural changes, we speculate
that the increased glomerular albumin permeability was
largely due to eGLX dysfunction.
Importantly, this is the ﬁrst demonstration that Ang1
could restore eGLX in glomeruli. In diabetic mice where Ang1
was overexpressed in a podocyte-dependent manner, albu-
minuria was signiﬁcantly reduced and endothelial cells were
shown to be protected. However, endothelial ultrastructure,
including the eGLX, was not studied in detail.15 Ang1
depletion in a type 1 model of diabetes substantially increased
albuminuria42 supporting the important role of Ang1 in renal
protection. We have previously shown that Ang1 can protect
against vascular endothelial barrier dysfunction though
modiﬁcation of the eGLX in vivo,16 but this study conﬁrms
for the ﬁrst time that Ang-1 also rapidly restores the eGLX
(within 30 minutes).
Not only have we demonstrated that this assay can be
applied to human glomeruli, but we have also demonstrated
that it can be used in conjunction with human clinical sam-
ples after nephrectomy. There is a continuing interest in the
ﬁeld to elucidate the mechanism behind circulating perme-
ability factors in SRNS patients and how they differ between
states of recurrence and remission.12,43,44 We have conﬁrmed
previous ﬁndings, that plasma from SRNS patients in recur-
rence causes a signiﬁcant increase in Ps’alb, whereas remission
does not.11 This demonstrates proof of principle that, not
only can we compare apparent Ps’alb in response to clinical
samples, but that human clinical samples could be used to
determine mechanism in human glomeruli, which is an
important leap forward for the ﬁeld.7
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glomerular permeability assay that can measure early decline
in glomerular permeability. This represents a new gold stan-
dard in ex vivo glomerular permeability measurement, and is
an important research tool that could be used in experimental
models and, critically, in human clinical samples to determine
human glomerular permeability.
CONCISE METHODS
All materials were purchased from Sigma-Aldrich (Dorset, UK)
unless otherwise stated.
All animal experiments performed were in accordance with UK
Home Ofﬁce regulations. All studies on human kidney tissue and
human SRNS plasma were approved by national and local research
ethics committees (Institutional Ethical Committee, Leiden Univer-
sity Medical Centre, The Netherlands; South West–Central Bristol
National Health Service Research Ethics Committee, UK; and East
Midlands–Leicester National Health Service Research Ethics Com-
mittee, UK), and conducted in accordance with the tenets of the
Declaration of Helsinki.
Rat glomeruli isolation and treatment
Adult male Sprague Dawley rats (Harlan Laboratories, UK) aged 6 to
8 weeks (200–380 g) (or 4 weeks after STZ) were anesthetized with
3.5% isoﬂurane and sodium pentobarbital 60 mg/ml given at 1 ml/g
of body weight. Once stable anesthesia had been achieved, the animal
was laid on its back. The abdominal aorta was then exposed with a
midline laparotomy and a cannula consisting of a 23-gauge, 1-inch
blunted needle (Terumo, UK) attached to thin laboratory tube
(0.58  0.19 mm; TUB3662, Scientiﬁc Laboratory Supplies, UK),
and it was placed in the infrarenal abdominal aorta (Figure 1ai and
ii). A clamp was applied above the branch point of the right kidney,
and a suture was pulled around the vena cava and abdominal aorta
below the cannulation site to maximize perfusion of the left kidney.
Both kidneys were perfused with 4% mammalian Ringer BSA so-
lution (NaCl, 132 mM; KCl, 4.6 mM; MgSO4-7H2O, 1.27 mM;
CaCl2-2H2O, 2 mM; NaHCO3, 25 mM; D[þ]glucose, 5.5 mM; N-2-
hydroxyethylpiperazine-N’-2-ethanesulphonic [HEPES] acid, 3.07
mM; HEPES sodium salt, 1.9 mM; 4% BSA, pH 7.40  0.01 using
115 mM HCl or NaOH to maintain osmolarity) containing R18,
(36.5 mg/ml, Thermo Fisher Scientiﬁc O-246) followed by AF488-
conjugated BSA (AF488-BSA, 30 mg/ml). Following exsanguination
and nephrectomy, glomeruli were isolated on ice by graded sieving
from the cortex of each kidney as previously described, with the
glomeruli collected from the 125 mm–gauge sieve.3 Glomeruli were
incubated in AF488-BSA on ice until use.
Mouse glomeruli isolation
Mice (including FVB/mixed background, bred in-house, male db/þ
lean mice age 12–14 weeks from the Jackson Laboratory, and adult
female C57BL/6 mice, 37–27 g from Charles River) were anes-
thetized using an i.p. injection of 200 to 800 ml of tribromoethanol
(133 mg/ml in 0.9% saline). The abdominal aorta was exposed and
cannulated with PE-10 tubing (427400; Becton Dickinson, Franklin
Lakes, NJ), and then the protocol was followed as for rats, except that
glomeruli were collected from the 75-mm sieve.
Human glomeruli isolation
Human kidneys were perfused with physiological salt solution, as
is standard practice for transplantation (which is useful for this8assay because it ﬂushes out red blood cells). Kidneys deemed
unsuitable for transplantation, from individuals 72  3.1 years of
age, were transported to the laboratory on ice up to 24 hours after
removal. Glomeruli were isolated as above and harvested from the
125-mm sieve, then centrifuged at 1200 rcf for 15 minutes to form
a pellet. The next step differed from the rodent protocols;
glomeruli were resuspended in R18 (36.5 mg/ml) on ice for 45
minutes, washed, and then incubated in AF488-BSA (30 mg/ml)
on ice until use.
Standardization of protocol across species
In some rats and mice the procedure was carried out as described,
yet kidneys were only perfused with Ringer-BSA. Sieved glomeruli
were subsequently incubated sequentially in R18, then AF488-BSA as
described for human kidneys.
Decellularization of isolated glomeruli
Isolated glomeruli (from rats, mice, and humans) were divided in 2
groups and either treated with vehicle or decellularized as
described previously by Ligler and Robinson,45 although modiﬁ-
cations were necessary to ensure the glomeruli maintained their
structure in order to identify capillary loops. Glomeruli were lysed
in N-lauroylsarcosine/Krebs (0.5%) for 45 minutes. After centri-
fugation (800 g for 5 minutes), they were resuspended in a 1%
TitonX100 solution for 3 minutes at room temperature. Glomeruli
were then centrifuged and the supernatant was removed. To
remove residual gel-like nucleoprotein, glomeruli were suspended
in a DNase solution (Precision HL DNase: 1ml of Precision DNase
enzyme þ 10X Precision DNase reaction buffer, product code:
AM2222; Primer Design, UK), vortexed, and allowed to stand for
30 minutes. The glomeruli were then centrifuged, the supernatant
was removed, and the resulting cell-free glomerulus preparation
was rinsed twice and resuspended in 4% BSA (pH 7.4). A fraction
of decellularized and vehicle-treated glomeruli were stained with
Höechst 33342 (0.001%) and imaged to verify the efﬁcacy of the
treatment. Vehicle-treated and decellularized glomeruli were then
incubated in AF488-BSA on ice until use.
Calibration of the glomerular albumin permeability assay
To determine the best time frame for data analysis, the decline in
ﬂuorescence intensity in ROI1 was calculated from varying periods
of time after the washout. Ps’alb values were compared between
vehicle-treated and decellularized glomeruli. A calibration curve of
known BSA concentrations was constructed using confocal micro-
scopy and circular ROI. The ﬂuorescent intensities were then plotted
against concentration. To test the effects of photobleaching on
AF488, several drops of AF488-BSA (30 mg/ml) were exposed to
continuous 488-wavelength laser scanner for 90 minutes (n ¼ 4). A
comparison was also made between FITC-dextran (30 mg/ml) and
AF488-dextran (30 mg/ml) exposed to continuous 488-wavelength
laser scanner for 5 minutes. To determine the amount of free dye
in a batch of AF488-BSA, the solution was centrifuged (3500 rpm for
30 minutes at room temperature) with Amicon Ultra-4 tubes
(Ultracel 30k; Millipore, Watford, Hertfordshire, UK). Solution
eluted from the column was compared with known concentrations
of AF488 free dye (Life Technologies, Loughborough, UK) using a
standard curve. The amount of free dye eluted from the column was
then tested using the Ps’alb assay. Brieﬂy, rat kidneys were perfused
with free dye and a single glomerulus was isolated and Ps’alb
measured, as detailed below for AF488-BSA.Kidney International (2018) -, -–-
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Mouse glomeruli were prepared as described above, but the AF488-BSA
was replaced with either HMW or LMW FITC-dextran (30 mg/ml,
FD500S or FD4-100M, respectively). After sieving, the perfused
glomeruli were incubated in the same solutions they were perfused with
(HMWor LMW FITC-dextran) and stored on ice until use.
Human SRNS plasma
Human exchange plasma samples were collected under ethical
consent from 4 separate patients with SRNS that had undergone
plasma exchange from periods when they were in posttransplant
recurrence, or subsequent remission, as detailed previously.21 Rat
glomeruli were isolated for the glomerular albumin permeability
assay, as described above, then incubated in the presence of AF488-
BSA for 1 hour at 37C with 10% recurrence or remission plasma.
Ps’alb measurements were taken directly afterwards (as described
below).
Systemic endothelial glycocalyx disruption
Chondroitinase (0.087 mU/g) and hyaluronidase (15 mU/g) in a
ﬁnal volume of 200 ml in saline (0.9%), or saline alone, were injected
into the tail vein of anesthetized FVB/mixed background mice, bred
in-house, between the ages of 10 to 12 week. Mice were maintained
under anesthesia at 37C for 30 minutes and then the protocol for
either glomerular albumin permeability (below) or whole-body
perfusion ﬁxation23 was followed. Pilot studies revealed that 1000
fold higher concentration of each, as used by Jeansson et al.,9 did not
reduce vessel eGLX coverage.
Isolated glomerular imaging
A Nikon Tie inverted confocal microscope stage was replaced with a
modiﬁed Petri dish with a thin glass coverslip (thickness: 0.085 mm;
Raymond A Lam Laboratory Supplies, East Sussex, UK) attached to
the top and connected to a perfusion syringe (20 ml) and a suction
system (peristaltic pump; Dylade Laboratories, Fresenius, UK)
(Figure 1b). The top of the microscope stage was also equipped with
a micromanipulator (Scientiﬁca, Uckﬁeld, UK) connected to a
restraining pipette. The restraining pipettes were made from boro-
silicate glass capillaries (1.2 mm in diameter; Harvard Apparatus,
Holliston, MA). The capillaries were heated within the coiled ﬁla-
ment of a Narishige P22 microelectrode puller (Narishige, Cam-
bridge, UK) and pulled to a ﬁne tip. The upper part of the
borosilicate capillary was exposed to a naked ﬂame for a brief
amount of time repeatedly, resulting in an angled pipette with a ﬁne
tip used to trap the glomeruli.
A single glomerulus was isolated from a population of glomeruli
(with no capsule and with the afferent and efferent arterioles still
attached) under the confocal microscope according to successful
labeling with R18 and AF488-BSA, and was secured in a perfusion
bath by lowering the restraining pipette. After 5 minutes of further
incubation with AF488-BSA, the glomerulus was imaged at 20X and
recorded using the ND Acquisition video tool of NIS-Element AR
(Nikon C1) software. The perfusion bath was then rapidly exchanged
(#1 minute) for an iso-oncotic ﬂuorescence-free BSA. Glomeruli
were scanned (1 frame every 4 seconds) for the duration of the
experiment using a 488-nm wavelength laser, a 543.3-nm wavelength
laser, and transmitted light. A pinhole limited the entrance of light to
the photodetector. The imaging window was 1024  1024 pixels. For
the whole experiment, the perfect focus system was left on to ensure
acquisition of images with the same focal plane. These settings,
including the gain, were kept the same for all experiments. Off-lineKidney International (2018) -, -–-analysis was performed using Nikon’s NIS Elements software. Only
single capillaries, circular in cross-section and at the periphery of the
glomerulus, containing labeled albumin, no red blood cells, and
surrounded by a large pool of unlabeled albumin, were used for the
analysis (Figure 1ci). The analysis was performed by drawing an ROI
inside both loop and perfusion bath. ROI measurements of green
ﬂuorescent intensity mean versus time (seconds) were recorded from
each experiment and plotted into a Cartesian coordinate system
(Figure 1cii). The green line (Figure 1cii) demonstrates that
the decline in ﬂuorescence intensity follows a single exponential
(R2¼ 0.97). Of note we observed that the ROI within the glomerulus
should be restricted to the capillary lumen and drawn without
capillary wall interference. Ps’alb was then calculated from the rate of
reduction of ﬂuorescence intensity inside the capillary lumen using
equations deﬁned below.
Calculation of Ps’alb values
The superﬁcial glomerular capillary is treated as a well-stirred
compartment from which the labeled albumin diffuses into the
bath where its concentration is maintained at zero. The decay in
ﬂuorescence intensity is analyzed in a similar manner to that
described by Daniels et al.6 From Fick’s ﬁrst law of diffusion, the rate
of diffusion of albumin molecules out of the capillary into the bath,
-dN/dt, is proportional to the difference in concentration of labeled
albumin molecules in the capillary and their concentration in the
bath, (CC-CB), and the product of the permeability coefﬁcient (PSalb)
and the area of capillary wall through which diffusion occurs, (S), as
follows:
dN
dt
¼ Psalb SðCC  CBÞ ¼ PSalbS

N
Vc
 CB

; (1)
where N ¼ the number of molecules in the capillary and VC ¼ the
capillary volume so that N/VC ¼ CC. The negative sign indicates that
labeled molecules are being lost from the capillary. If the concen-
tration of labeled albumin in the bath is kept at 0, equation 1 reduces
to the following:
dN
dt
¼ PSalb$ S
VC
$N (2)
Equation 2 can be immediately integrated to describe the loss of
labeled albumin molecules with time as follows:
N ¼ Noekt ; (3)
where k ¼ PS’albS/VC and N0 ¼ the number of labeled molecules at
0 time.
Because ﬂuorescent intensity reﬂects the number of ﬂuorescent
albumin molecules in the region of interest (Figure 1d), equation 3
can be written as follows:
If ¼ if0ekt ; (4)
where If0 is ﬂuorescent intensity at 0 time. The following expresses
equation 4 as natural logarithms:
InðIf Þ ¼ InIf0 kt (5)
Thus, there will be a linear fall in ln(If) with time, and when
plotted in Cartesian coordinates the negative slope of the relation is
k. Providing the capillary is cylindrical in shape (and knowing the
diameter of the capillary loop remains unchanged during the
experiment, data not shown) the ratio of S/VC is 2/R, where R is the9
bas i c re sea r ch S Desideri et al.: Glomerular albumin permeabilitycapillary radius. PSalb may then be calculated from k, because of the
following:
PSalb ¼ kR=2 (6)
The minute following the wash period was the most appropriate
to analyze (Figure 1g).
Electron micrograph analysis
The Alcian blue ﬁxed kidneys (and in some cases hearts) were
processed for electron microscopy as previously described,23 imaged
with a Technai 12 electron microscope (FEI, Hillsboro, Oregon), and
analyzed with ImageJ (SciJava software ecosystem) under blinded
conditions. The following were quantiﬁed on a grid section: eGLX
depth, below 10 nm was considered “uncovered” and was expressed
as a percentage of total measurements taken on a grid section; GBM
length; podocyte and fenestration number per mm GBM; podocyte
foot process width; and slit diaphragm width. GBM was measured
using a grid tool for random sampling, and a minimum of 3 points
were analyzed in each image (3 capillary loops per glomerulus and
2–3 glomeruli per animal) as previously described.23
Diabetes model
Diabetes was induced in 6- to 8-week-old (200–380 g) adult male
Sprague Dawley rats (Harlan Laboratories, UK) with a single dose of
STZ, as previously described.22 Diabetes developed over 4 weeks, and
glycemia, body weight, and urine were monitored or collected
weekly. Glycemia was monitored via tail-tip blood droplets using an
Accu-check (Aviva; Roche Diabetes Care, Burgess Hill, UK) gluc-
ometer. STZ-injected rats with glycemia <15 mM at week 1 were
excluded from the analysis. Rat urine albumin was quantiﬁed using a
rat albumin enzyme-linked immunosorbent assay (Nephrat; Exocell,
Philadelphia, PA) according to the manufacturer’s instructions.
Urine creatinine was quantiﬁed using an enzymatic assay (Thermo
Fisher Scientiﬁc) on a Konelab Clinical Chemistry Analyser at the
Langford Biochemistry Laboratory, University of Bristol, UK. At 4
weeks after injection (STZ or vehicle), glomerular albumin perme-
ability was measured or rats were tail-vein injected with Ang1 (ﬁnal
blood concentration 200 ng/ml, corrected for body weight) or
vehicle (0.1% BSA) for 30 minutes, as previously described for
in vivo treatment,16 then terminally anesthetized. One kidney was
perfusion-ﬁxed via an abdominal aorta cannula, as described above
for cardiac perfusion ﬁxation in the mouse, and the tissue was
processed for electron microscopy.
Rat parafﬁn-embedded kidney sections from nonperfused kid-
neys were stained using a periodic acid–Schiff kit according to the
manufacturer’s instructions. Images were quantiﬁed with ImageJ
using the H PAS color deconvolution plug-in. Corrected total cell
intensity values were calculated as follows: intergraded density (area
of glomerulus  background mean gray value). Ten glomeruli were
analyzed per rat.
Statistics
All statistical analyses were performed on a minimum of 3 separate
replicates. Data are presented as means  SEM. A P value <0.05 was
considered statistically signiﬁcant. For glomerular permeability
experiments, n is indicated as follows: ﬁrst number represents the
number of animals and, in parentheses, the number of glomeruli
analyzed for each group; that is, n ¼ 3(9) indicates 9 glomeruli from
3 different animals. The number of animals was used for statistical
analysis.10DISCLOSURE
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Figure S1. Isolated glomeruli restrict the passage of high–molecular
weight (HMW) proteins. (A) The relationship between HMW and
low–molecular weight (LMW) dextran concentration and ﬂuorescent
intensity is shown (LMW R2 ¼ 0.99, HMW R2 ¼ 0.97). HMW (500 kDa)
and LMW (4 kDa) ﬂuorescein isothiocyanate (FITC)-conjugated
dextran were perfused into mouse kidneys, and glomeruli were
isolated. (B) apparent glomerular albumin permeability (Ps’alb)
(permeability [cm/s]) was compared between FITC 500-kDa and FITC
4-kDa dextran (unpaired t test, number of animals indicated and
number of glomeruli bracketed). Statistical analyses were performed
on the number of animals. (Ci) Fluorescent decay of FITC-dextran
(n ¼ 7) was compared with ﬂuorescent decay of AF488-dextran
(n ¼ 8) over 300 seconds and (Cii) quantiﬁed over a relevant time
frame to analysis (100–120 seconds) (unpaired t test). **P < 0.001,
***P < 0.0001.
Figure S2. The effect of perfusion with Ringer alone and of time on
Ps’alb. The kidneys of (A) rats and (B) mice (lean db/þ) were perfused
with Ringer, followed in some cases by R18, then Alexa Fluor 488
bovine serum albumin (AF488-BSA; Ringer þ ﬂuorophores) and in
other cases after Ringer perfusion (Ringer), the kidney was removed,
and the glomeruli isolated and incubated ﬁrst in R18 then AF488 to
compare the rodent protocol with the human protocol (unpaired t
tests). (C) Glomeruli from mice (1-year-old C57BL/6) isolated on the
same day were left for 1, 2, 3, or 4 hours on ice before Ps’alb was
measured (1-way analysis of variance). (D) Kidneys from the same
mice were sieved on the day of use (same day) or left on ice in the
refrigerator for 24 hours before being sieved (24 hours later) and
glomerular Ps’alb compared (unpaired t test). ***P < 0.001.
Supplementary material is linked to the online version of the paper at
www.kidney-international.org.
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